Clinical Trials
2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Rapid Diagnostic Test for Influenza
- Conditions
- Influenza
- First Posted Date
- 2010-03-19
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- Meso Scale Diagnostics, LLC.
- Target Recruit Count
- 569
- Registration Number
- NCT01089816
- Locations
- π»π³
National Hospital of Pediatrics, Ha Noi, Vietnam
π»π³Children's Hospital #2, Ho Chi Minh City, Vietnam
π»π³Children's Hospital 1, Ho Chi Minh City, Vietnam
Clinical Validation of the Point-of-Care MSD Influenza Test
- Conditions
- Influenza Human
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2012-03-01
- Lead Sponsor
- Meso Scale Diagnostics, LLC.
- Target Recruit Count
- 391
- Registration Number
- NCT00863343
- Locations
- πΊπΈ
Naval Health Research Center, San Diego, California, United States
πΊπΈDartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
πΊπΈJohn T Mather Hospital, Port Jefferson, New York, United States
News
Bioanalysis Emerges as Critical Foundation for Precision Medicine Development
β’ Bioanalytical techniques are driving precision medicine forward through three key areas: biomarker identification, therapeutic response monitoring, and development of targeted drugs for specific patient groups. β’ Advanced technologies like mass spectrometry, single-cell analysis, and CRISPR-based diagnostics are revolutionizing biomarker detection and validation, with HER2 testing in breast cancer demonstrating remarkable success. β’ Complex challenges in pharmacokinetic and pharmacodynamic studies, including individual patient variability and regulatory requirements, necessitate sophisticated bioanalytical approaches for successful precision medicine development.
